Healthcare

According to a market report by Lucintel, the future of the clinical trial supply market looks promising with opportunities in the pharmaceutical & biotechnology companies, contract research organisations, and medical device companies. The global clinical trial supply market is expected to reach an estimated $4 billion by 2028 with a CAGR of 7.7% from 2023 to 2028. The major drivers for this market are increasing R&D expenditure by the pharmaceutical and biotechnology companies, growing prevalence of diseases, and the globalization of clinical trials.



In this market, oncology, CNS and mental disorders, cardiovascular diseases, digestive disorders, infectious diseases, metabolic disorders, immunology, and blood disorders are the major therapeutic area segments. Lucintel forecasts that oncology are expected to remain the largest segment over the forecast period as pharmaceutical and biotechnology companies are focusing on bringing innovative cancer drugs into the market.

Within this market, pharmaceutical and biotechnology is expected to remain the largest segment over the forecast period due to increasing in number of clinical trails being conducted pharmaceutical and biotechnology companies to develop new drugs and treatment that drives the market.



APAC is expected to witness the highest growth over the forecast period due to growing demand of new and effective drugs and the region is large with diverse population that provides a large pool of potential clinical trial participant for drug development companies.

Thermo Fisher Scientifi, Marken, Catalent, Eurofins Scientific, and PRA Health Sciences are the major suppliers in the global clinical trial supply market.



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global clinical trial supply market by service, type, therapeutic area, end use industry, and region. Lucintel has compiled a comprehensive research report titled “Growth Opportunities in the Global Clinical Trial Supply Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global clinical trial supply market by service, type, therapeutic area, end use industry, and region, as follows:

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the clinical trial supply market by service (logistics & distribution, storage & retention, packaging, labeling, and blinding, manufacturing, and comparator sourcing), type (small-molecules, biologic drugs, and medical devices), therapeutic area (oncology, CNS and mental disorders, cardiovascular diseases, digestive disorders, infectious diseases, metabolic disorders, immunology, and blood disorders), end use industry(pharmaceutical & biotechnology companies, contract research organisations, and medical device companies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?

Q.11. What M&A activity did occur in the last five years and how did they impact the industry?